Venlafaxine Hydrochloride Capsule, Extended Release
Product Images NDC 71335-1642

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 71335-1642). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl713351642)

Label Image (Lbl713351642)
This is a description of the medication Venlafaxine ER 150mg Capsule which is packaged by Bryant Ranck Prepack Bunbauk. This medication is an opaque dark orange capsule that is stored at a room temperature of 20°-25°C (68°-77°F). The drug is to be kept out of reach of children, kept tightly closed and is compared to Effexor XR 150mg Capsule. The manufacturer of this medication is Aurobindo Pharma Limited, and the package contains 6 capsules with an expiration date of MM/YY. The NDC number for this medication is 7133516421.*
FDA Label Image

Figure 1: Effect Of Interacting Drugs On The Pharmacokinetics Of Venlafaxine And Active Metabolite O-desmethylvenlafaxine (odv). (Venlafaxine Fig1)

Figure 1: Effect Of Interacting Drugs On The Pharmacokinetics Of Venlafaxine And Active Metabolite O-desmethylvenlafaxine (odv). (Venlafaxine Fig1)
This is a report on an interacting drug called "cimetane" which affects the analyte "aniatxine" and two related compounds, "veniatxine" and "venistaxing". The report provides PK fold change and 90% confidence intervals recommendations on the maximum value and concentration of the drug, cautioning against use in patients with hypertension or hepatic dysfunction. The report notes unknown clinical significance of some of the changes and recommends caution in use and monitoring blood pressure. No information is available on the relative change to any reference value.*
FDA Label Image

Figure 2: Effect Of Venlafaxine On The Pharmacokinetics Interacting Drugs And Their Active Metabolites. (Venlafaxine Fig2)

FDA Label Image

Figure 3: Pharmacokinetics Of Venlafaxine And Its Metabolite O-desmethylvenlafaxine (odv) In Special Populations. (Venlafaxine Fig3)

FDA Label Image

Chemical Structure (Venlafaxine Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.